Perspectum has announced a collaboration with UT Southwestern Medical Center, to include LiverMultiScan® technology in the Dallas Heart & Minds Study (DHMS).
Perspectum reports the DHMS initial aim was to improve the diagnosis, prevention and treatment of heart disease, over the years this has expanded to encompass metabolic diseases, such as fatty liver disease.
LiverMultiScan’s quantitative MRI technology will be used to measure chronic liver disease, enabling a deeper understanding of the interactions between genetics, environment and lifestyle on the health of the liver.
LiverMultiScan is currently being used across Dallas, and the US, to enable physicians to better diagnose and treat patients with disorders such as Fatty Liver Disease. Using a non-invasive MRI, the test gives metrics of liver tissue health that correlate with inflammation, fibrosis, fat, and iron.
“We are really excited to work with Perspectum on the Dallas Hearts and Minds Study, formerly known as Dallas Heart Study. In the previous examinations, we extensively characterized obesity and cardiometabolic risk factors in our cohort – we are about to gain critical knowledge of how long-standing obesity and metabolic syndrome can affect liver health using LiverMultiScan by Perspectum.” Dr. Jaret Berry, Principal Investigator, Dallas Heart and Minds Study
“As part of our efforts to improve the care of patients, we are using LiverMultiScan to assess the liver in this large DHMS cohort hoping to further our understanding of obesity phenotyping in the liver.” – Dr. Carlos Duncker, Medical Science Liaison, Perspectum.
